206 related articles for article (PubMed ID: 31582779)
1. A novel miRNA-4484 is up-regulated on microarray and associated with increased MMP-21 expression in serum of systemic sclerosis patients.
Rusek M; Michalska-Jakubus M; Kowal M; Bełtowski J; Krasowska D
Sci Rep; 2019 Oct; 9(1):14264. PubMed ID: 31582779
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
Chouri E; Servaas NH; Bekker CPJ; Affandi AJ; Cossu M; Hillen MR; Angiolilli C; Mertens JS; van den Hoogen LL; Silva-Cardoso S; van der Kroef M; Vazirpanah N; Wichers CGK; Carvalheiro T; Blokland SLM; Giovannone B; Porretti L; Marut W; Vigone B; van Roon JAG; Beretta L; Rossato M; Radstake TRDJ
J Autoimmun; 2018 May; 89():162-170. PubMed ID: 29371048
[TBL] [Abstract][Full Text] [Related]
3. Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.
Tanaka S; Suto A; Ikeda K; Sanayama Y; Nakagomi D; Iwamoto T; Suzuki K; Kambe N; Matsue H; Matsumura R; Kashiwakuma D; Iwamoto I; Nakajima H
Rheumatology (Oxford); 2013 Nov; 52(11):1963-72. PubMed ID: 23893664
[TBL] [Abstract][Full Text] [Related]
4. Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients.
Zhou B; Zuo XX; Li YS; Gao SM; Dai XD; Zhu HL; Luo H
Sci Rep; 2017 Feb; 7():42899. PubMed ID: 28211533
[TBL] [Abstract][Full Text] [Related]
5. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.
Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
Front Immunol; 2018; 9():449. PubMed ID: 29559981
[TBL] [Abstract][Full Text] [Related]
6. Identification and Interaction Analysis of Key Genes and MicroRNAs in Systemic Sclerosis by Bioinformatics Approaches.
Sun YH; Xie M; Wu SD; Zhang J; Huang CZ
Curr Med Sci; 2019 Aug; 39(4):645-652. PubMed ID: 31347003
[TBL] [Abstract][Full Text] [Related]
7. Impact of alterations in X-linked IRAK1gene and miR-146a on susceptibility and clinical manifestations in patients with systemic sclerosis.
Vreca M; Andjelkovic M; Tosic N; Zekovic A; Damjanov N; Pavlovic S; Spasovski V
Immunol Lett; 2018 Dec; 204():1-8. PubMed ID: 30308218
[TBL] [Abstract][Full Text] [Related]
8.
He Y; Liu H; Wang S; Chen Y
DNA Cell Biol; 2019 Sep; 38(9):933-944. PubMed ID: 31361540
[TBL] [Abstract][Full Text] [Related]
9. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
[TBL] [Abstract][Full Text] [Related]
10. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
11. Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis.
Rossato M; Affandi AJ; Thordardottir S; Wichers CGK; Cossu M; Broen JCA; Moret FM; Bossini-Castillo L; Chouri E; van Bon L; Wolters F; Marut W; van der Kroef M; Silva-Cardoso S; Bekker CPJ; Dolstra H; van Laar JM; Martin J; van Roon JAG; Reedquist KA; Beretta L; Radstake TRDJ
Arthritis Rheumatol; 2017 Sep; 69(9):1891-1902. PubMed ID: 28556560
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of differentially expressed microRNAs in systemic sclerosis.
Zhang L; Wu H; Zhao M; Lu Q
Int J Rheum Dis; 2020 Oct; 23(10):1297-1304. PubMed ID: 32761884
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
Zhu H; Luo H; Zuo X
Exp Mol Med; 2013 Sep; 45(9):e41. PubMed ID: 24052166
[TBL] [Abstract][Full Text] [Related]
14. The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.
Steen SO; Iversen LV; Carlsen AL; Burton M; Nielsen CT; Jacobsen S; Heegaard NH
J Rheumatol; 2015 Feb; 42(2):214-21. PubMed ID: 25399392
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression.
Vahidi Manesh P; Farazmand A; Gharibdoost F; Vanaki N; Mostafaei S; Kavosi H; Mahmoudi MB; Mahmoudi M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):173-181. PubMed ID: 31066253
[TBL] [Abstract][Full Text] [Related]
16. MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling.
Yao Q; Xing Y; Wang Z; Liang J; Lin Q; Huang M; Chen Y; Lin B; Xu X; Chen W
Aging (Albany NY); 2020 Dec; 13(2):2640-2654. PubMed ID: 33411678
[TBL] [Abstract][Full Text] [Related]
17. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1.
Zhou B; Zhu H; Luo H; Gao S; Dai X; Li Y; Zuo X
Biomed Pharmacother; 2017 Mar; 87():412-418. PubMed ID: 28068631
[TBL] [Abstract][Full Text] [Related]
19. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
20. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
